[Phase 3 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism--a multi-center trial].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples